HSA — authorised 29 May 2013
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇸🇬 Tafinlar in Singapore
HSA authorised Tafinlar on 29 May 2013
Marketing authorisation
Tafinlar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Tafinlar approved in Singapore?
Yes. HSA authorised it on 29 May 2013.
Who is the marketing authorisation holder for Tafinlar in Singapore?
NOVARTIS PHARMS CORP holds the Singaporean marketing authorisation.